UDIBI

Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS

Fecha de publicación: 27 de febrero de 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus...

Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....

Batch-to-batch reproducibility of Transferon™ VER MÁS

Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps. VER MÁS

Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....

Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. VER MÁS

Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...